256 related articles for article (PubMed ID: 2176247)
21. [HCG and SP-1 as markers in trophoblast tumors. The HCG/SP-1 ratio].
Than GN; Tatra G; Csaba IF; Szabo DG; Bohn H
Gynakol Rundsch; 1988; 28(3):157-65. PubMed ID: 2844633
[No Abstract] [Full Text] [Related]
22. Evaluation of the beta-Neocept test for early pregnancy.
Yuen BH; Pride SM; Callegari PB
Can Med Assoc J; 1984 Sep; 131(6):583-5. PubMed ID: 6206935
[TBL] [Abstract][Full Text] [Related]
23. Human chorionic gonadotropin, its free subunits and gestational trophoblastic disease.
Ozturk M
J Reprod Med; 1991 Jan; 36(1):21-6. PubMed ID: 1706779
[TBL] [Abstract][Full Text] [Related]
24. Human chorionic gonadotropin assays and their uses.
Tyrey L
Obstet Gynecol Clin North Am; 1988 Sep; 15(3):457-75. PubMed ID: 2852329
[TBL] [Abstract][Full Text] [Related]
25. Enzyme immunoassay for human chorionic gonadotropin and its clinical application.
Tomoda S
Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1085-94. PubMed ID: 6272526
[TBL] [Abstract][Full Text] [Related]
26. A highly sensitive and specific sandwich enzyme immunoassay for detection of human chorionic gonadotropin in trophoblastic disease.
Ibuki Y; Yazaki K; Igarashi M
Asia Oceania J Obstet Gynaecol; 1990 Mar; 16(1):49-56. PubMed ID: 2160806
[TBL] [Abstract][Full Text] [Related]
27. Application of the radioreceptor assay for human chorionic gonadotropin in pregnancy testing and management of trophoblastic disease.
Boyko WL; Russell HT
Obstet Gynecol; 1977 Sep; 50(3):324-32. PubMed ID: 197458
[TBL] [Abstract][Full Text] [Related]
28. The need for an hCG assay that appropriately detects trophoblastic disease and other hCG-producing cancers.
Cole LA; Kohorn EI
J Reprod Med; 2006 Oct; 51(10):793-811. PubMed ID: 17086808
[TBL] [Abstract][Full Text] [Related]
29. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
Elmer DB; Granai CO; Ball HG; Curry SL
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
[TBL] [Abstract][Full Text] [Related]
30. Persistent trophoblast disease following partial molar pregnancy.
Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
[TBL] [Abstract][Full Text] [Related]
31. Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels.
Cole LA; Kohorn EI; Kim GS
J Reprod Med; 1994 Mar; 39(3):193-200. PubMed ID: 8035374
[TBL] [Abstract][Full Text] [Related]
32. Elevated HCG outside of pregnancy--diagnostic considerations and laboratory evaluation.
Olsen TG; Barnes AA; King JA
Obstet Gynecol Surv; 2007 Oct; 62(10):669-74; quiz 691. PubMed ID: 17868485
[TBL] [Abstract][Full Text] [Related]
33. [Clinical significance of HCG and subunit analysis in endocrine tests of the gonadal and placental system].
Ibuki Y; Igarashi M; Yazaki K
Nihon Rinsho; 1989 Dec; 48 Suppl():1279-85. PubMed ID: 2560075
[No Abstract] [Full Text] [Related]
34. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
[TBL] [Abstract][Full Text] [Related]
35. Monitoring of trophoblastic neoplasms through radioimmunoassay of the urinary carboxy-terminal fragment of beta-choriogonadotropin (COOH-beta-HCG-RIA).
Ayala AR; González E; Castorena G; de Jesús Montoya J
Arch Invest Med (Mex); 1984; 15(2):139-45. PubMed ID: 6207791
[No Abstract] [Full Text] [Related]
36. [Diagnostic significance of tumor markers for gynecologic malignancies].
Aoki D; Hirasawa A; Susumu N
Gan To Kagaku Ryoho; 2005 Mar; 32(3):411-6. PubMed ID: 15791829
[TBL] [Abstract][Full Text] [Related]
37. [Monoclonal antibodies against the beta subunit of human chorionic gonadotropin].
Fidler R; Sokolov AV; Verbitskiĭ MSh; Papazov IP
Biull Eksp Biol Med; 1988 Dec; 106(12):693-5. PubMed ID: 2462933
[TBL] [Abstract][Full Text] [Related]
38. [Studies on enzymeimmunoassay for human chorionic gonadotropin and its clinical application].
Kobayashi O; Shirotake S; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jun; 35(6):764-72. PubMed ID: 6308107
[TBL] [Abstract][Full Text] [Related]
39. Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor.
Tuncer ZS; Bernstein MR; Goldstein DP; Berkowitz RS
Gynecol Oncol; 1999 Jun; 73(3):345-7. PubMed ID: 10366457
[TBL] [Abstract][Full Text] [Related]
40. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
Kohorn EI; Kacinski BM; Stanley ER
Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
